CompletedNCT01691092
Brain Glutamate Imaging During Ketamine Research for Depression
About this title
Read the official source — NCT01691092Medication studyAges 18–65United StatesPTSD
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
What did participation involve?
The study group receives ketamine as a study medication.
- Listed locations
- New Haven and 2 more locationsSee all locations and recruitment
Study information
Study start dateJune 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 79
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01691092
- Official title
Show the full official title
PET Imaging of mGluR5 With Drug Challenge
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 65 years.
